Kimberly Winges

Assistant Professor

  • 154 Citations
  • 5 h-Index
If you made any changes in Pure these will be visible here soon.

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 3 Similar Profiles
Optical Coherence Tomography Medicine & Life Sciences
Multiple Sclerosis Medicine & Life Sciences
Nerve Fibers Medicine & Life Sciences
Cerebrospinal Fluid Medicine & Life Sciences
Chronic Progressive Multiple Sclerosis Medicine & Life Sciences
Thioctic Acid Medicine & Life Sciences
Optic Atrophy Medicine & Life Sciences
Relapsing-Remitting Multiple Sclerosis Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2018

  • 154 Citations
  • 5 h-Index
  • 8 Article

Vision loss from choroidal and pituitary metastases secondary to renal cell carcinoma: a case report

Selby, L. D., Stiefel, H. C., Skalet, A. H., Cardenal, M. S., Bhavsar, K. V. & Winges, K. M., Jun 18 2018, (Accepted/In press) In : Neuro-Ophthalmology. p. 1-8 8 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Subretinal Fluid
Neoplasm Metastasis
Optic Chiasm

Vitreopapillary traction detected by optical coherence tomography

Simonett, J. M. & Winges, K. M., May 1 2018, In : JAMA Ophthalmology. 136, 5, e180727

Research output: Contribution to journalArticle

Optical Coherence Tomography
10 Citations

Lipoic acid in secondary progressive MS

Spain, R., Powers, K., Murchison, C., Heriza, E., Winges, K., Yadav, V., Cameron, M., Kim, E., Horak, F., Simon, J. & Bourdette, D., 2017, In : Neurology: Neuroimmunology and NeuroInflammation. 4, 5, 374

Research output: Contribution to journalArticle

Thioctic Acid
1 Citations
Chronic Progressive Multiple Sclerosis
Optic Atrophy
Optical Coherence Tomography
Multiple Sclerosis
14 Citations

Baseline retinal nerve fiber layer thickness and macular volume quantified by OCT in the north American phase 3 fingolimod trial for relapsing-remitting multiple sclerosis

Winges, K. M., Werner, J. S., Harvey, D. J., Cello, K. E., Durbin, M. K., Balcer, L. J., Calabresi, P. A. & Keltner, J. L., Dec 2013, In : Journal of Neuro-Ophthalmology. 33, 4, p. 341-348 8 p.

Research output: Contribution to journalArticle

Relapsing-Remitting Multiple Sclerosis
Optical Coherence Tomography
Nerve Fibers
Multiple Sclerosis
Quality Control